80 related articles for article (PubMed ID: 16172791)
41. IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation.
Borowiec AS; Hague F; Harir N; Guénin S; Guerineau F; Gouilleux F; Roudbaraki M; Lassoued K; Ouadid-Ahidouch H
J Cell Physiol; 2007 Sep; 212(3):690-701. PubMed ID: 17520698
[TBL] [Abstract][Full Text] [Related]
42. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.
Tan M; Li P; Sun M; Yin G; Yu D
Oncogene; 2006 Jun; 25(23):3286-95. PubMed ID: 16407820
[TBL] [Abstract][Full Text] [Related]
43. Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA.
Jiang J; Jedinak A; Sliva D
Biochem Biophys Res Commun; 2011 Nov; 415(2):325-9. PubMed ID: 22033405
[TBL] [Abstract][Full Text] [Related]
44. Vitamin E analog alpha-TEA and celecoxib alone and together reduce human MDA-MB-435-FL-GFP breast cancer burden and metastasis in nude mice.
Zhang S; Lawson KA; Simmons-Menchaca M; Sun L; Sanders BG; Kline K
Breast Cancer Res Treat; 2004 Sep; 87(2):111-21. PubMed ID: 15377836
[TBL] [Abstract][Full Text] [Related]
45. Regulation of intracellular calcium levels and urokinase activity in MDA MB 231 cells by quercetin.
Devipriya S; Vani G; Ramamurthy N; Shyamaladevi CS
Chemotherapy; 2006; 52(2):60-5. PubMed ID: 16462139
[TBL] [Abstract][Full Text] [Related]
46. Celecoxib and 2,5-dimethyl-celecoxib prevent cardiac remodeling inhibiting Akt-mediated signal transduction in an inherited dilated cardiomyopathy mouse model.
Fan X; Takahashi-Yanaga F; Morimoto S; Zhan DY; Igawa K; Tomooka K; Sasaguri T
J Pharmacol Exp Ther; 2011 Jul; 338(1):2-11. PubMed ID: 21430081
[TBL] [Abstract][Full Text] [Related]
47. Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
Ko HS; Kim JS; Cho SM; Lee HJ; Ahn KS; Kim SH; Lee EO
Bioorg Med Chem Lett; 2014 Feb; 24(4):1176-9. PubMed ID: 24440300
[TBL] [Abstract][Full Text] [Related]
48. Urokinase plasminogen activator (uPA) is a positive regulator of outer root sheath keratinocyte proliferation.
Cui ZH; Yang T; Gao QG; Wang Y
Cell Biol Int; 2004; 28(8-9):571-5. PubMed ID: 15350591
[TBL] [Abstract][Full Text] [Related]
49. Sodium Salicylate Inhibits Urokinase Activity in MDA MB-231 Breast Cancer Cells.
Madunić J; Horvat L; Majstorović I; Jodłowska I; Antica M; Matulić M
Clin Breast Cancer; 2017 Dec; 17(8):629-637. PubMed ID: 28456486
[TBL] [Abstract][Full Text] [Related]
50. Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin.
Nielsen TO; Andrews HN; Cheang M; Kucab JE; Hsu FD; Ragaz J; Gilks CB; Makretsov N; Bajdik CD; Brookes C; Neckers LM; Evdokimova V; Huntsman DG; Dunn SE
Cancer Res; 2004 Jan; 64(1):286-91. PubMed ID: 14729636
[TBL] [Abstract][Full Text] [Related]
51. Enhanced stability of urokinase-type plasminogen activator mRNA in metastatic breast cancer MDA-MB-231 cells and LLC-PK1 cells down-regulated for protein kinase C--correlation with cytoplasmic heterogeneous nuclear ribonucleoprotein C.
Nanbu R; Montero L; D'Orazio D; Nagamine Y
Eur J Biochem; 1997 Jul; 247(1):169-74. PubMed ID: 9249023
[TBL] [Abstract][Full Text] [Related]
52. Molecular mechanisms of the 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced inverted U-shaped dose responsiveness in anchorage independent growth and cell proliferation of human breast epithelial cells with stem cell characteristics.
Ahn NS; Hu H; Park JS; Park JS; Kim JS; An S; Kong G; Aruoma OI; Lee YS; Kang KS
Mutat Res; 2005 Nov; 579(1-2):189-99. PubMed ID: 16051281
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and evaluation of non-basic inhibitors of urokinase-type plasminogen activator (uPA).
Venkatraj M; Messagie J; Joossens J; Lambeir AM; Haemers A; Van der Veken P; Augustyns K
Bioorg Med Chem; 2012 Feb; 20(4):1557-68. PubMed ID: 22285569
[TBL] [Abstract][Full Text] [Related]
54. DMC: novel celecoxib derivatives to rap cancer.
Dent P; Yacoub A; Grant S
Cancer Biol Ther; 2005 May; 4(5):583-4. PubMed ID: 15970676
[No Abstract] [Full Text] [Related]
55. Effects of celecoxib on the expression of osteoprotegerin, energy metabolism and cell viability in cultured human osteoblastic cells.
Kolar P; Lach S; Gaber T; Maschmeyer P; Dziurla R; Tripmacher R; Krocker D; Matziolis G; Perka C; Burmester GR; Buttgereit F
Clin Exp Rheumatol; 2009; 27(1):99-107. PubMed ID: 19327236
[TBL] [Abstract][Full Text] [Related]
56. [Inhibited proliferation and expression of human nasopharyngeal carcinoma line induced by celecoxib in vitro].
Jiang DH; Guo DY; Li HZ; Deng W
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Nov; 41(11):809-12. PubMed ID: 17283531
[TBL] [Abstract][Full Text] [Related]
57. Cytotoxicity of the Urokinase-Plasminogen Activator Inhibitor Carbamimidothioic Acid (4-Boronophenyl) Methyl Ester Hydrobromide (BC-11) on Triple-Negative MDA-MB231 Breast Cancer Cells.
Longo A; Librizzi M; Chuckowree IS; Baltus CB; Spencer J; Luparello C
Molecules; 2015 May; 20(6):9879-89. PubMed ID: 26029857
[TBL] [Abstract][Full Text] [Related]
58. Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties.
Bruncko M; McClellan WJ; Wendt MD; Sauer DR; Geyer A; Dalton CR; Kaminski MA; Weitzberg M; Gong J; Dellaria JF; Mantei R; Zhao X; Nienaber VL; Stewart K; Klinghofer V; Bouska J; Rockway TW; Giranda VL
Bioorg Med Chem Lett; 2005 Jan; 15(1):93-8. PubMed ID: 15582418
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of urokinase-type plasminogen activator expression by dihydroartemisinin in breast cancer cells.
Zhang S; Ma Y; Jiang J; Dai Z; Gao X; Yin X; Xi W; Min W
Oncol Lett; 2014 May; 7(5):1375-1380. PubMed ID: 24765140
[TBL] [Abstract][Full Text] [Related]
60. 3-Amidinophenylalanine-based inhibitors of urokinase.
Stürzebecher J; Vieweg H; Steinmetzer T; Schweinitz A; Stubbs MT; Renatus M; Wikström P
Bioorg Med Chem Lett; 1999 Nov; 9(21):3147-52. PubMed ID: 10560742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
